Neurodegenerative Disease News and Research

RSS

CytRx granted "Fast Track" designation for ALS drug

CytRx Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted "Fast Track" designation for the company's leading drug candidate arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

26 Sep 2005

Green tea may protect the brain against Alzheimer's disease

Researchers at the University of South Florida (USF) have found that green tea may offer another potential health benefit - protecting the brain against the ravages of Alzheimer's disease.

20 Sep 2005

Study points to link to neurodegenerative disease target

A University of California - San Francisco (UCSF) study has found that a specific signaling link between neurons and muscles in the fruit fly is essential for keeping the insect's nervous system stable.

1 Sep 2005

Biochemical switch that affects how neurons fire in a part of the brain associated with learning

Researchers at UT Southwestern Medical Center have identified a biochemical switch that affects how neurons fire in a part of the brain associated with learning, findings that may aid in understanding schizophrenia and Alzheimer's disease.

17 Aug 2005

Power3 converts provisional patent applications

Power3 Medical Products announced today that it has converted two provisional patent applications by the filing of two utility patent applications with the United States Patent and Trademark Office for the Company's disease specific biomarker discovery and disease specific immuno- diagnostic test designs.

4 Aug 2005

Aging profile of the human brain differs greatly from that seen in chimpanzees

Researchers have found that the two primary areas of the human brain appear to age in radically different ways: The cortex used in higher-level thought undergoes more extensive changes with age than the cerebellum, which regulates basic processes such as heartbeat, breathing and balance.

2 Aug 2005

Living Cell Technologies announces results for treating Huntington's disease

Living Cell Technologies announced pre-clinical results today showing its brain protection product, NeurotrophinCell (NtCell) produces a marked reduction in the size of brain lesions in a Huntington's disease (HD) model.

2 Aug 2005

New clues for the understanding of dementia

Researchers at the Medical Research Council MRC Prion Unit and the Department of Neurodegenerative Disease at the Institute of Neurology, University College London - in collaboration with groups from Copenhagen, Aarhus, Lund and Cambridge - have identified a gene that, when mutated, causes an early onset dementia.

24 Jul 2005

Diagnostic test for Lou Gehrig's disease

Bowser is director of the ALS Tissue Bank and an Associate Professor of Pathology at the University of Pittsburgh School of Medicine who is using a key piece of biomarker discovery equipment known as SELDI to find new ways to identify and eventually treat Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease.

1 Jun 2005

Diet rich in vitamin E may protect against Parkinson's disease

In a meta-analysis to try to establish whether vitamin C, vitamin E, and carotene can lower the risk of Parkinson's disease (PD), scientists have found that diets rich in vitamin E could protect against the development of PD.

18 May 2005

Search for new multiple sclerosis drug

UT Southwestern Medical Center is the lead research site testing a new treatment for a rare form of multiple sclerosis. Called "primary progressive," this type of MS affects about 15 percent of patients with the neurodegenerative disease.

26 Apr 2005

Researchers insert engineered human stem cells into the spinal cords of ALS-afflicted rats

Unveiling a delivery method that may one day help surgeons treat the deadly neurodegenerative disease amyotrophic lateral sclerosis (ALS), researchers at the University of Wisconsin-Madison have inserted engineered human stem cells into the spinal cords of ALS-afflicted rats.

19 Apr 2005

Blue-green algae linked to Alzheimer's disease

An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.

5 Apr 2005

Step toward a potential treatment for Huntington's disease

Researchers at the University of Iowa Roy J. and Lucille A. Carver College of Medicine have taken another step toward a potential treatment for Huntington's disease (HD). Using an approach called RNA interference (RNAi), the scientists reduced levels of the disease-causing HD protein in mice and significantly improved the movement and neurological abnormalities normally associated with the disease.

4 Apr 2005